STRATA CRITICAL MEDICAL, INC. Foreign Currency Transaction Gain (Loss), Realized
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Foreign Currency Transaction Gain (Loss), Realized of $798.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-03-03
- STRATA CRITICAL MEDICAL, INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. foreign currency transaction gain (loss), realized for the quarter ending 2024-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. foreign currency transaction gain (loss), realized for fiscal 2025 was $798.00K.
- STRATA CRITICAL MEDICAL, INC. foreign currency transaction gain (loss), realized for fiscal 2024 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $798.00K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $798.00K 10-Q · filed 2025-11-10 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 10-K · filed 2026-03-03 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | ||
| 2023-09-30 | -$6.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |